Solvay posts Q3 2026 results hit by Middle East conflict, cuts 2026 EBITDA guidance and announces interim dividend
Solvay reported third‑quarter 2026 underlying net sales of €1,031 million, down 3.3% year‑on‑year, and underlying EBITDA of €173 million, down 26.6% YoY, largely because of a €‑25 million impact from the Middle East conflict and a temporary shutdown of its Peroxides plant in Jubail. The board approved an interim dividend of €0.97 per share. The company revised its 2026 EBITDA outlook to €720‑€740 million and free‑cash‑flow outlook to €120‑€150 million.
Why it matters
The lower EBITDA and free‑cash‑flow guidance signal reduced earnings potential for 2026, while the €260 million dividend payout exceeds the upper end of the free‑cash‑flow range, raising questions about dividend sustainability. Investors will watch whether Q4 cash generation can meet the guidance floor.
Key facts
- 1Underlying net sales in Q3 2026 were €1,031 million, down 3.3% YoY. finanznachrichten.de
- 2Underlying EBITDA in Q3 2026 was €173 million, down 26.6% YoY. finanznachrichten.de
- 3The Middle East conflict caused an EBITDA impact of €‑25 million in the quarter. finanznachrichten.de
- 4The interim dividend approved was €0.97 gross per share. finanznachrichten.de
- 5Revised 2026 underlying EBITDA guidance is €720 million to €740 million. finanznachrichten.de
- 6Revised 2026 free cash flow guidance is €120 million to €150 million. finanznachrichten.de
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.